98
edits
Difference between revisions of "Lung tumours"
Jump to navigation
Jump to search
→IHC
(→IHC: wikify) |
(→IHC) |
||
| Line 93: | Line 93: | ||
Note: | Note: | ||
*CD56 - cytoplasmic.<ref>URL: [http://jcp.bmjjournals.com/content/58/9/978.full http://jcp.bmjjournals.com/content/58/9/978.full]. Accessed: 11 February 2010.</ref> | *CD56 - cytoplasmic.<ref>URL: [http://jcp.bmjjournals.com/content/58/9/978.full http://jcp.bmjjournals.com/content/58/9/978.full]. Accessed: 11 February 2010.</ref> | ||
===Adenocarcinoma=== | |||
*[[TTF-1]] +ve. | |||
*[[Napsin]] +ve - sensitive.<ref name=pmid22288963>{{cite journal |author=Turner BM, Cagle PT,Fukuoka J, ''et al'' |title=Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma: Evaluation of 1674 Cases by Tissue Microarray |journal=Arch Pathol Lab Med. |volume=136 |issue=10 |pages=163-71 |year=2012 |month=February|pmid=22288963 |doi: 10.5858/arpa.2011-0320-OA|url=}}</ref> | |||
*[[CK7]] +ve, [[CK20]] -ve. | |||
===Squamous cell carcinoma=== | ===Squamous cell carcinoma=== | ||